Guardant Health
GH
#1557
Rank
$13.32 B
Marketcap
$102.62
Share price
-0.57%
Change (1 day)
188.83%
Change (1 year)
Guardant Health is an American company developing blood tests for early detection in high-risk populations and recurrence monitoring in cancer survivors.

Guardant Health (GH) - Total assets

Total assets on the balance sheet as of September 2025 : $1.27 Billion USD

According to Guardant Health 's latest financial reports the company's total assets are $1.27 Billion USD. A companyโ€™s total assets is the sum of all current and non-current assets, such as inventories, cash and cash equivalents, properties and equipment.

Guardant Health - Total assets on balance sheet (from 2017 to 2025)

Total assets by year

Year Total assets Change
2024-12-31$1.48 B-16.84%
2023-12-31$1.78 B10.96%
2022-12-31$1.60 B-26.97%
2021-12-31$2.20 B-2.96%
2020-12-31$2.27 B136.02%
2019-12-31$0.96 B63.86%
2018-12-31$0.58 B71.29%
2017-12-31$0.34 B194.2%
2016-12-31$0.11 B

Total Assets for similar companies or competitors

Company Total assets differencediff. Country
Natera
NTRA
$1.82 B 42.66%๐Ÿ‡บ๐Ÿ‡ธ USA
Neogen
NEOG
$3.37 B 164.58%๐Ÿ‡บ๐Ÿ‡ธ USA